Search
Dextromethorphan
go.drugbank.com/drugs/DB00514ApprovedInvestigational[A215412] Dextromethorphan was granted FDA approval before 3 December 1957.[A215412,L14997]
Mixtures: K.B. FEDAMOLProducts: K.B. DEXTRO TABLETSVerapamil
go.drugbank.com/drugs/DB00661ApprovedInvestigationalVerapamil is a phenylalkylamine calcium channel blocker used in the treatment of high blood pressure, heart arrhythmias, and angina, and was the first calcium channel antagonist to be introduced into therapy in the early 1960s. It is a m...
Products: VERAPAMIL RATIO 120MG FTA, VERAPAMIL RATIO N 40MG FTASildenafil
go.drugbank.com/drugs/DB00203ApprovedInvestigationalIn eliciting its mechanism of action, sildenafil ultimately prevents or minimizes the breakdown of cyclic guanosine monophosphate (cGMP) by inhibiting cGMP specific phosphodiesterase type 5 (PDE5) . The result of doing so allows cGMP pre...
Products: REVATIO 20MG FTA, GRANPIDAM 20MG FTAFerrous cation
go.drugbank.com/drugs/DB14510InvestigationalProducts: HAEMOPROCAN 50MG FTA, HAEMOPROCAN 100MG FTARosuvastatin
go.drugbank.com/drugs/DB01098ApprovedInvestigationalRosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiti...
Products: CRESTOR 5MG FTA, CRESTOR 10MG FTAEfavirenz
go.drugbank.com/drugs/DB00625ApprovedInvestigationalEfavirenz (brand names Sustiva® and Stocrin®) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type ...
Products: EFAVIRENZ HEXAL 600MG FTAMoxifloxacin
go.drugbank.com/drugs/DB00218ApprovedInvestigationalMoxifloxacin is a synthetic fluoroquinolone antibiotic agent. Bayer AG developed the drug (initially called BAY 12-8039) and it is marketed worldwide (as the hydrochloride) under the brand name Avelox (in some countries also Avalox) for ...
Products: MOXIFLOXACIN AL 400MG FTA, MOXIFLOXACIN HEU 400MG FTAEdoxaban
go.drugbank.com/drugs/DB09075ApprovedInvestigationalTraditionally, warfarin, a vitamin K antagonist, was used for stroke prevention in these individuals but effective use of this drug is limited by it's delayed onset, narrow therapeutic window, need for … In addition to once daily dosing, the benefits over warfarin also include significant reductions in hemorrhagic stroke and GI bleeding, and improved compliance, which is beneficial as many patients will
Tadalafil
go.drugbank.com/drugs/DB00820ApprovedInvestigational[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH.
Products: TALMANCO 20MG FTA, TADALAFIL AOP 20MG FTATenofovir disoproxil
go.drugbank.com/drugs/DB00300ApprovedInvestigationalTenofovir disoproxil was initially approved in 2001 [FDA label].
Products: VIREAD 245MG FTA